Connection

John Lazarchick to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications John Lazarchick has written about Antibodies, Monoclonal, Humanized.
John Lazarchick
Connection Strength
0.442
Antibodies, Monoclonal, Humanized
  1. Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell ('Berti') lymphoma after administration of adalimumab. J Am Acad Dermatol. 2014 Sep; 71(3):e86-7.
    View in: PubMed
    Score: 0.442
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.